Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q3 2015 · 10-Q
Revenue$766.00K$766.00K+47.9% vs Q3 2014 Net Income$1.52M$1.52MN/M vs Q3 2014 EPS Diluted$0.15$0.15N/M vs Q3 2014 Gross Profit$264,000+45.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flowderived-$6,158,000N/M Free Cash Flowderived-$6,205,000N/M Margins · derivedGross margin34.5%−0.5 pt vs Q3 2014
Operating margin260.7%+1783.9 pt vs Q3 2014
Net margin198.4%+2010.2 pt vs Q3 2014
ended Sep 30, 2015 · filed Nov 6, 2015 · 37 d after period end